Gabriella Pravettoni

University of Milan, European Institute of Oncology

Papers

4

Total Citations

68

H-Index

4

About

Gabriella Pravettoni is a leading researcher in psycho-oncology and health psychology, with a focus on patient-reported outcomes and quality of life (QoL) in cancer care. Her major contributions center on validating and applying robust psychometric tools to measure QoL in prostate and lung cancer patients, ensuring culturally adapted instruments for Italian populations. For instance, her validation of the Italian EPIC-26 (20 citations) and EORTC QLQ-C30 (15 citations) provides clinicians with reliable metrics to assess treatment impacts. She also investigates clinical predictors of QoL, such as in her study of one-year trends after lung cancer lobectomy (19 citations), which identifies factors influencing recovery and survival. Beyond QoL, Pravettoni explores innovative surgical techniques, as seen in her work comparing confocal microscopy to frozen section analysis for prostate cancer margin evaluation (14 citations), advancing precision in radical prostatectomy. Her research bridges oncology and psychology, directly enhancing patient-centered care. With a consistent citation record, Pravettoni’s work is instrumental in shaping evidence-based practices that prioritize patients’ lived experiences alongside clinical outcomes, making her a key figure in integrating QoL metrics into routine cancer management.

Research Focus

Key Achievements

4
H-Index
4
Papers
68
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Validation of the Italian version of the abbreviated expanded prostate Cancer index composite (EPIC-26) in men with prostate Cancer
20 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: University of Milan, European Institute of Oncology

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago